Signup · Epionce

Select Gift

  • Our Approach
  • Products
  • Our Story
  • Why a Skin Care Professional
  • The Magazine
Signup ›


  • What's New

  • Bright Eyes Duo 20% OFF >

    Bright Eyes Duo

  • All About the Eyes New Blog >

    All About the Eyes
  • Epionce Near You   Nearby  
  • Login


Bright Eyes Duo All About the Eyes
Epionce Logo Epionce Logo
  • 0

  • Bright Eyes Duo 20% OFF >

    All About the Eyes New Blog >

  • Epionce Near You  
  • Login


    No Account? Signup ›

  • Our Approach
  • Products
  • Our Story
  • Why a Skin Care Professional
  • The Magazine

Signup

Already have an account? Login.

Don't have a Professional?

You may qualify for FREE shipping!
Connect with a Professional Near You.

Find Nearby Professionals

Required Field





Choose your web browser from below:

  • Chrome
  • Firefox
  • Safari
  • Internet Explorer
  • Microsoft Edge
  • Opera

  • Dr. Carl
  • Returns
  • Shipping Policy
  • FAQ
  • Customer Service
  • Contact Us
  • Your Story
  • Education
  • International
  • Press Center
  • Careers
  • Our Guarantee

Sign up for emails with the latest news, offers, and announcements from Epionce:

  • Dr. Carl
  • Returns
  • Shipping Policy
  • FAQ
  • Customer Service
  • Contact Us
  • Your Story
  • Education
  • International
  • Press Center
  • Careers
  • Our Guarantee

The U.S. Food and Drug Administration (FDA) defines cosmetics as "articles...applied to the human body...for cleansing, beautifying, promoting attractiveness, or altering the appearance." The majority of Epionce® products described on this website are intended to meet this definition. These Epionce® products and their associated statements have not been approved or evaluated by the FDA and are not intended to be drug products that diagnose, treat, cure, or prevent any disease or condition.

Epionce Ultra Shield SPF 50 and Daily Shield Tinted SPF 50 are considered over-the-counter drug products. They are formulated and marketed pursuant to the FDA’s governing regulations set forth at 21 C.F.R. Part 352.

USA Canada United Kingdom Hong Kong Japan Poland The Netherlands

Privacy Policy | Legal | Sitemap

© 2022 Episciences, Inc.
All Rights Reserved Worldwide